Gallbladder mass with a carbohydrate antigen 19-9 level in the thousands: malignant or benign pathology? Report of a case

Surg Today. 2007;37(4):342-4. doi: 10.1007/s00595-006-3377-4. Epub 2007 Mar 26.

Abstract

Tumor markers such as carbohydrate antigen 19-9 (CA 19-9) are commonly measured in the serum of patients with suspected pancreaticobiliary malignancies. Moderate elevations of CA 19-9 may be seen in benign disease, but levels in the thousands are indicative of malignancy. We report the case of a 64-year-old man with an elevated CA 19-9 of 5791 U/ml and radiological findings suggestive of metastatic gallbladder carcinoma. The patient underwent cholecystectomy and excision of a common bile duct stricture, with hepaticojejunostomy and liver biopsy. The final surgical pathology was consistent with xanthogranulomatous cholecystitis (XGC) and the elevated CA 19-9 returned to normal postoperatively. Thus, an elevated CA 19-9 level, even in the thousands, should not preclude patients from an operation if a mass is deemed resectable. Thorough investigation and treatment may result in a curative operation even if unresectable malignant disease is initially suspected.

Publication types

  • Case Reports

MeSH terms

  • Biomarkers, Tumor / blood*
  • CA-19-9 Antigen / blood*
  • Cholecystectomy
  • Cholecystitis / blood*
  • Cholecystitis / surgery
  • Diagnosis, Differential
  • Granuloma / blood*
  • Granuloma / surgery
  • Humans
  • Male
  • Middle Aged
  • Xanthomatosis / blood*
  • Xanthomatosis / surgery

Substances

  • Biomarkers, Tumor
  • CA-19-9 Antigen